Nanotechnology News
Explore nanotechnology trends and innovations in nanoscale science and engineering. From medical advancements to material science, stay informed on how nanotechnology transforms industries and drives the future of small-scale innovations.
Aug 10, 2026 at 9:00 AM
Discovered Materials Closes $9M Seed Round to Accelerate the Adoption of New Materials for Semiconductor Chips
SAN FRANCISCO--(BUSINESS WIRE)--Today, Discovered Materials, a company building AI agents that discover and accelerate the adoption of new materials for semiconductor chips, announces a $9M seed round. They also released hundreds of new materials discovered by frontier AI models, along with Material Discovery Bench - the first benchmark for agentic materials discovery on real-world semiconductor chip problems. The round is led by Lightspeed India Partners, with participation from Y Combinator a...
Aug 10, 2026 at 8:00 AM
Onto Innovation Completes Strategic Investment in Rigaku Holdings Corporation
WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation completes strategic investment in Rigaku, strengthening collaboration on next-generation X-ray process control....
Aug 6, 2026 at 4:05 PM
Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced business updates and financial results for the second quarter ended June 30, 2026. Recent Business Highlights Cash and cash equivalents totaled $101.6 million as of June 30, 2026. During Q2 the Company raised $46.8 million in net proceeds through an at-the-market (ATM) program, raising approxim...
Aug 6, 2026 at 4:05 PM
Onto Innovation Reports 2026 Second Quarter Results
WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation reports record Q2 2026 revenue of $343M, strong AI-driven demand, and backlog surpassing $1 billion....
Aug 6, 2026 at 12:01 PM
Emergence Appoints Ian Eslick as Chief Executive Officer
NEW YORK--(BUSINESS WIRE)--Emergence, a frontier agentic AI lab advancing safe autonomous AI, today announced the appointment of Ian Eslick as Chief Executive Officer. Eslick will lead the company's next phase of commercial growth, scaling enterprise adoption of Emergence's technology, expanding its go-to-market strategy, and driving operational execution as organizations increasingly deploy autonomous AI systems across mission-critical environments. As part of this evolution, Co-Founder Dr. Sa...
Aug 4, 2026 at 9:00 AM
Fi and Verizon Partner to Integrate Connected Pet Care into the Modern Family Ecosystem
NEW YORK--(BUSINESS WIRE)--Fi, a leader in smart pet technology, and Verizon are bringing connected pet care directly into the modern family ecosystem. By integrating Fi’s state-of-the-art Fi Mini™ tracker directly into the newly redesigned Verizon Family app, the collaboration creates the industry’s first unified safety dashboard built for every member of the household—two-legged and four-legged alike. While traditional family plans treat pets as an afterthought, together Verizon and Fi are de...
Aug 4, 2026 at 8:35 AM
CMS and MaxLinear Expand OpenZFS Storage for AI, Cloud, and Hyperscale Infrastructure
CARLSBAD, Calif.--(BUSINESS WIRE)--CMS adopts MaxLinear's Panther platform to accelerate OpenZFS storage for AI, cloud, hyperscale, and enterprise infrastructure....
Aug 4, 2026 at 8:00 AM
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 44,434 restricted stock units (“RSUs”) will be granted to 24 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist. The employment inducement awards will be granted under Twist’s Amended and Res...
Aug 4, 2026 at 7:00 AM
Bruker Reports Second Quarter 2026 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and six months ended June 30, 2026. Frank H. Laukien, Bruker’s President and CEO, commented: “We returned to organic revenue growth in the second quarter and our Scientific Instruments segment achieved 10% organic bookings growth year-over-year. Our focus on cost and profitability resulted in solid margin expansion and non-GAAP EPS growth in the quarter. In particular, we achieve...
Aug 3, 2026 at 8:00 PM
Pathos AI Enters Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERα PROTAC for ER+ Breast Cancer into the Clinic
NEW YORK--(BUSINESS WIRE)--Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a collaboration and co-exclusive licensing agreement with AstraZeneca. Under this agreement, the companies will advance AZD4241, a preclinical investigational therapy for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer, with Pathos assuming responsibility for the early clinical devel...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.